| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9610(01)00724-3 |
| P698 | PubMed publication ID | 11720667 |
| P2093 | author name string | S E Singletary | |
| P2860 | cites work | A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer | Q77713875 |
| Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy | Q77983563 | ||
| Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group | Q33897753 | ||
| Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why? | Q34163495 | ||
| Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy | Q39540808 | ||
| A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors | Q41242105 | ||
| Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma | Q42171964 | ||
| A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors | Q43562925 | ||
| The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer | Q45173064 | ||
| Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer | Q45627568 | ||
| Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. | Q50507373 | ||
| Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. | Q50508821 | ||
| Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. | Q54073250 | ||
| Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity | Q68192835 | ||
| Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study | Q69944251 | ||
| Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer | Q70997885 | ||
| Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials | Q71523388 | ||
| Conservation surgery after primary chemotherapy in large carcinomas of the breast | Q71558092 | ||
| Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm | Q72117965 | ||
| Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6 | Q72175084 | ||
| Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer | Q72616300 | ||
| Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients | Q73327586 | ||
| Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma | Q73402063 | ||
| The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy | Q73549642 | ||
| Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience | Q73585192 | ||
| Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer | Q73998097 | ||
| Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute | Q74082953 | ||
| Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS) | Q74604115 | ||
| Effect of preoperative chemotherapy on the outcome of women with operable breast cancer | Q77093352 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| neoadjuvant chemotherapy | Q108855558 | ||
| P304 | page(s) | 341-346 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | The American Journal of Surgery | Q15762745 |
| P1476 | title | Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer | |
| P478 | volume | 182 |
| Q44791826 | Development of malignant breast microcalcifications after neoadjuvant chemotherapy in advanced breast cancer |
| Q34793805 | Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival |
| Q33778433 | Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis |
| Q33994633 | Prognostic Factors in Patients with Stage II/III Breast Cancer Treated with Adjuvant Extension of Neoadjuvant Chemotherapy: A Retrospective Cohort Study with Ten-Years of Follow-Up Data |
| Q35203753 | Reassessing the role of axillary lymph-node dissection in patients with early-stage breast cancer |
| Q44937077 | Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma |
| Q44614427 | The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer |
| Q36646627 | Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management |
Search more.